190 related articles for article (PubMed ID: 38272918)
1. MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides.
Chang YT; Prompsy P; Kimeswenger S; Tsai YC; Ignatova D; Pavlova O; Iselin C; French LE; Levesque MP; Kuonen F; Bobrowicz M; Brunner PM; Pascolo S; Hoetzenecker W; Guenova E
Nat Commun; 2024 Jan; 15(1):752. PubMed ID: 38272918
[TBL] [Abstract][Full Text] [Related]
2. Immune privilege disruption in folliculotropic mycosis fungoides: investigation of major histocompatibility complex antigen expression.
Deonizio JMD; Guitart J; Yazdan P; Mulinari-Brenner F; Sotto MN; Sanches JA
Int J Dermatol; 2018 Jun; 57(6):675-680. PubMed ID: 29603194
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
[TBL] [Abstract][Full Text] [Related]
6. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
8. Role of B-cells in Mycosis Fungoides.
Nielsen PR; Eriksen JO; Sørensen MD; Wehkamp U; Lindahl LM; Bzorek M; Iversen L; Woetman A; Ødum N; Litman T; Gjerdrum LMR
Acta Derm Venereol; 2021 Mar; 101(3):adv00413. PubMed ID: 33686443
[TBL] [Abstract][Full Text] [Related]
9. Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma.
Hamrouni A; Fogh H; Zak Z; Ødum N; Gniadecki R
Clin Cancer Res; 2019 May; 25(10):3104-3114. PubMed ID: 30808775
[TBL] [Abstract][Full Text] [Related]
10. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C
Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.
Kinney MC; Jones D
Am J Clin Pathol; 2007 May; 127(5):670-86. PubMed ID: 17439828
[TBL] [Abstract][Full Text] [Related]
12. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
Mahmoud AB; Tu MM; Wight A; Zein HS; Rahim MM; Lee SH; Sekhon HS; Brown EG; Makrigiannis AP
PLoS Pathog; 2016 Feb; 12(2):e1005446. PubMed ID: 26928844
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors.
Sjöström A; Eriksson M; Cerboni C; Johansson MH; Sentman CL; Kärre K; Höglund P
J Exp Med; 2001 Nov; 194(10):1519-30. PubMed ID: 11714758
[TBL] [Abstract][Full Text] [Related]
14. Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours.
Filtjens J; Keirsse J; Van Ammel E; Taveirne S; Van Acker A; Kerre T; Taghon T; Vandekerckhove B; Plum J; Van Ginderachter JA; Leclercq G
Sci Rep; 2016 Jul; 6():30564. PubMed ID: 27469529
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
[TBL] [Abstract][Full Text] [Related]
16. Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.
Glasner A; Oiknine-Djian E; Weisblum Y; Diab M; Panet A; Wolf DG; Mandelboim O
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878071
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire.
Held W; Dorfman JR; Wu MF; Raulet DH
Eur J Immunol; 1996 Oct; 26(10):2286-92. PubMed ID: 8898935
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
Rubio Gonzalez B; Zain J; Rosen ST; Querfeld C
Curr Opin Oncol; 2016 Jan; 28(1):88-96. PubMed ID: 26632770
[TBL] [Abstract][Full Text] [Related]
20. The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules.
Belicha-Villanueva A; Riddell J; Bangia N; Gollnick SO
Lasers Surg Med; 2012 Jan; 44(1):60-8. PubMed ID: 22246985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
